行情

VCEL

VCEL

Vericel
NASDAQ

实时行情|Nasdaq Last Sale

38.31
-1.88
-4.68%
休市 16:00 11/26 EST
开盘
39.38
昨收
40.19
最高
40.32
最低
37.37
成交量
27.21万
成交额
--
52周最高
68.94
52周最低
24.31
市值
17.93亿
市盈率(TTM)
-1212.3418
分时
5日
1月
3月
1年
5年
First Washington CORP Buys Air Products & Chemicals Inc, Lockheed Martin Corp, NorthWestern ...
GuruFocus News · 11/12 18:23
Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021
CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the Canaccor...
GlobeNewswire · 11/11 13:30
Vericel Corporation (VCEL) Reports Q3 Loss, Misses Revenue Estimates
Zacks.com · 11/09 13:55
Recap: Vericel Q3 Earnings
  Vericel (NASDAQ:VCEL) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM. Here's what investors need to know about the announcement.
Benzinga · 11/09 13:13
Vericel EPS misses by $0.08, misses on revenue
Vericel (NASDAQ:VCEL): Q3 GAAP EPS of -$0.11 misses by $0.08. Revenue of $34.5M (+6.8% Y/Y) misses by $3.57M. Shares +0.53% PM. Press Release Gross margin of 64%, compared to 70%
Seekingalpha · 11/09 12:46
Vericel Q3 EPS $(0.11) Misses $(0.03) Estimate, Sales $34.51M Miss $38.07M Estimate
Vericel (NASDAQ:VCEL) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.03) by 266.67 percent. This is a 237.5 percent decrease over earnings of $0.08 per share from the
Benzinga · 11/09 12:45
BRIEF-Vericel Reports Q3 Loss Per Share Of $0.11
reuters.com · 11/09 12:42
-- Earnings Flash (VCEL) VERICEL CORPORATION Posts Q3 Revenue $34.5M, vs. Street Est of $38.1M
MT Newswires · 11/09 07:56
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解VCEL最新的财务预测,通过VCEL每股收益,每股净资产,每股现金流等数据分析Vericel近期的经营情况,然后做出明智的投资选择。
分析师评级

6位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

66.67%强力推荐
33.33%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测VCEL价格均价为58.96,最高价位68.00,最低价为50.00。
最高68.00
均价58.96
最低50.00
现价38.31
EPS
实际EPS
预期EPS
-0.030.060.140.23
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 285
机构持股: 6,441.53万
持股比例: 137.59%
总股本: 4,681.53万
类型机构数股数
增持
81
378.60万
建仓
20
33.56万
减持
71
153.20万
平仓
23
76.39万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-0.45%
制药与医学研究
+0.44%
高管信息
Non-Executive Chairman/Independent Director
Robert Zerbe
President/Chief Executive Officer/Director
Dominick Colangelo
Chief Financial Officer/Chief Accounting Officer
Joseph Mara
Chief Operating Officer
Michael Halpin
Vice President/General Counsel/Secretary
Sean Flynn
Other
Jonathan Hopper
Independent Director
Steven Gilman
Independent Director
Heidi Hagen
Independent Director
Kevin Mclaughlin
Independent Director
Alan Rubino
Independent Director
Paul Wotton
Independent Director
Lisa Wright
暂无数据
VCEL 简况
Vericel Corporation是一家综合的商业阶段生物制药公司,致力于鉴定、开发和商业化帮助身体修复与再生损伤组织与器官以恢复正常结构与功能的疗法。该公司从事治疗特定疾病的细胞疗法的研究、产品开发、制造和分销业务。该公司的自体细胞治疗产品包括Epicel(培养的表皮自体移植物),这是一种永久性的皮肤替代物,用于治疗深度皮肤或全层烧伤患者。该公司正在开发第三代自体软骨细胞植入物MACI和患者特异性多细胞疗法ixmyelocel-T。

微牛提供Vericel Corp(NASDAQ-VCEL)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的VCEL股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易VCEL股票基本功能。